NMIN’s Founding Scientific Director Dr. Pieter Cullis delivers his keynote presentation at Vancouver Nanomedicine Day 2023. Credit: Oleksii Popov / UBC Faculty of Pharmaceutical Sciences For the fourth consecutive time, NMIN was a proud supporter of Vancouver Nanomedicine Day in its 2023 iteration. The conference took place 15 November 2023… Read More »NMIN in the spotlight at Vancouver Nanomedicine Day 2023
L to R: NMIN Executive Director Dr. Diana Royce; HQP Logan Zettle; NMIN Associate Scientific Director Dr. Afsaneh Lavasanifar; President of NMIN’s NHN Executive Committee, Jennyfer Zapata-Farfan; and NHN Executive member Amélie Baron at the DeepTech event in Edmonton, AB. NMIN participation was significant in the event “From Innovation to… Read More »NMIN well represented at Deep Tech event
Dr. Pieter Cullis, NMIN’s Founding Scientific Director, has been named as a 2024 inductee into the Canadian Medical Hall of Fame (CMHF). “I am incredibly honoured,” said Dr. Cullis. “The lipid nanoparticle (LNP) technology enabling the COVID-19 mRNA vaccines reflect the efforts of literally hundreds of people. I have been… Read More »Pieter Cullis named 2024 Canadian Medical Hall of Fame inductee
L to R: PhD candidate Matthew Nguyen, who was lead author on the study, and NMIN research leader Dr. Warren Chan NMIN-supported research out of the University of Toronto lab of NMIN research leader Dr. Warren Chan sheds new light on the mechanisms by which nanoparticles enter and exit the… Read More »NMIN researchers elucidate mechanism of nanoparticle tumour delivery
Bottom left: Vega Bioimaging’s Julien Fillion & Arnaud Latreille hold the Student Entrepreneurship Prize trophy Two of NMIN’s six spin-off companies received external validation in July 2023, in the form of a funding commitment for one and an entrepreneurship prize for the other. As reported by CPE News on 24… Read More »Funding, prize for NMIN spin-offs Liberum Bio & Vega BioImaging
NMIN’s Founding Scientific Director Dr. Pieter Cullis has been elected a Fellow of the Royal Society, the UK’s national academy of sciences and the oldest science academy in continuous existence. Dr. Cullis is one of 80 new Fellows selected “for their substantial contribution to the advancement of science.” Past Fellows… Read More »Pieter Cullis elected Fellow of Royal Society
The NanoMedicines Innovation Network (NMIN) is pleased to introduce the 2023-24 Executive Committee of its Highly Qualified Personnel (HQP) Network – the NMIN HQP Network (NHN). The NHN Executive Committee is comprised entirely of NMIN HQP, and plays a leadership role in the planning and realization of NMIN’s HQP programs,… Read More »Announcing the 2023-24 NHN Executive Committee
The NanoMedicines Innovation Network (NMIN) is pleased to announce 19 new recipients of NMIN Advanced Training Certification (ATC), who were celebrated in an online ceremony on 30 May 2023. https://youtu.be/5d5OQoSc9pQ Watch the presentation ceremony NMIN’s Advanced Training Certification, or ATC, recognizes an individual’s engagement in diverse capacity-building activities offered by… Read More »Nineteen new recipients of NMIN’s Advanced Training Certification (ATC) announced
Dr. Pieter Cullis (centre) is flanked by Dr. Laurel Schafer (R), who nominated him for the award, and NMIN researcher Dr. Christine Allen (L), who is Vice-President, Ecosystem Development, for adMare Bioinnovations. Inset: Dr. Julia Levy. On 18 April 2023, NMIN’s Founding Scientific Director Dr. Pieter Cullis was presented the… Read More »Pieter Cullis wins 2023 Julia Levy Award
On March 15, 2023, NMIN’s Founding Scientific Director Dr. Pieter Cullis was announced as a recipient of a 2023 Killam Prize. “The achievements and aspirations of the 2023 Killam Laureates have a significant impact on our society,” Maydianne Andrade, Chair, National Killam Selection Committee, was quoted as saying in the… Read More »Pieter Cullis wins 2023 Killam Prize